Medicaments: containing alkaloids or their derivatives, containing ephedrine or its salts, for therapeutic or prophylactic uses, packaged for retail sale

In 2024, medicaments: containing alkaloids or their derivatives, containing ephedrine or its salts, for therapeutic or prophylactic uses, packaged for retail sale trade exhibited significant decline, with global flows reaching $56,875,191 and a three-year compound annual growth rate of -2.5% (five-year: -4.1%). The all-time peak of $161,110,442 was recorded in 2017; the current level is 65% below that high-water mark.

Over the 30-year observation window (1995–2024), 55% of years recorded positive growth, indicating a mildly upward trajectory with periodic contractions. Trend momentum is strengthening (+3.8% acceleration).

The supply side is diversified (Herfindahl-Hirschman Index 0.083). The three largest exporters — United Kingdom ($38.9M), France ($11.4M), and Germany ($8.2M) — collectively dominate supply flows. The leading exporter has grown at -26.3% over the last three years.

On the demand side, importer concentration is moderately concentrated (HHI 0.160). The three largest import markets are United States ($21.8M), Egypt ($3.0M), and Germany ($2.0M). The largest importing market sources from 7 different supplying countries.

The dominant trade corridor is United Kingdom → United States at $35.6M, representing 60.1% of the importer's total demand.

The volatility score for medicaments: containing alkaloids or their derivatives, containing ephedrine or its salts, for therapeutic or prophylactic uses, packaged for retail sale is 22 out of 100, classified as low. Trade flows are relatively stable compared to other HS6 products, suggesting mature supply chains and predictable demand.

For market entrants, contracting demand signals caution before committing resources. The diversified supply landscape means many competitors but also multiple entry points and buyer relationships to target.

Data confidence is rated "High" based on reporting coverage and consistency across OECD member and partner countries.